Travere Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Travere Therapeutics's estimated annual revenue is currently $73.6M per year.(i)
  • Travere Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Travere Therapeutics has 475 Employees.(i)
  • Travere Therapeutics grew their employee count by -10% last year.

Travere Therapeutics's People

NameTitleEmail/Phone
1
Sr. VP, Regulatory Affairs and QualityReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Pharmacovigilance & Renal Clinical DevelopmentReveal Email/Phone
4
VP, Insights, Analysis and SystemsReveal Email/Phone
5
VP, Information TechnologyReveal Email/Phone
6
VP, Head Corporate CommunicationsReveal Email/Phone
7
SVP, General Counsel & SecretaryReveal Email/Phone
8
VP Regulatory AffairsReveal Email/Phone
9
VP LegalReveal Email/Phone
10
VP, US SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Travere Therapeutics?

At Travere Therapeutics, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife

keywords:N/A

N/A

Total Funding

475

Number of Employees

$73.6M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Travere Therapeutics News

2022-04-20 - Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected to Earn ...

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) – Investment analysts at Jefferies Financial Group issued their Q2 2022 earnings per...

2022-04-19 - Is Travere Therapeutics Inc (TVTX) Stock a Smart Value Tuesday?

Travere Therapeutics Inc gets a 82 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors. Overall Score - 72. TVTX has an...

2022-04-17 - Where Does Travere Therapeutics Inc (TVTX) Stock Fall in the Biotechnology Field After It Is Down -4.09% This Week?

The 61 rating InvestorsObserver gives to Travere Therapeutics Inc (TVTX) stock puts it near the top of the Biotechnology industry.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$150.8M4754%N/A
#2
$120.7M481-20%N/A
#3
$108.5M482N/AN/A
#4
$60.4M4834%N/A
#5
$87.5M48350%N/A